1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. NEUROCRINE BIOSCIENCES, INC.
Neurocrine Biosciences, Inc. XNAS: NBIX
Mid-range Performer
136.76 2.57 (1.92%)
62.36% Gain from 52W Low
1.4M
XNAS Volume

XNAS 30 Jul, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Neurocrine Biosciences, Inc. is on 01 Aug 2025 for the purpose of Neurocrine Biosciences Inc Second Quarter Earnings Results for 2025 See details

Detailed Stock Analysis for Neurocrine Biosciences, Inc. with Real-time Stock Report

crown icon
Premium Feature
Please subscribe to Pro or ProPlus
Subscribe Sign in